This filing is an amendment. It supersedes 0002048497-26-000013, which remains published.
Sale of 35,994 shares at $18.4628 per share.
Reporting Person Hopman Mark · Officer Title Chief Commercial Officer · Transaction Code S
Traded Sep 9, 2026 · Disclosed Sep 18, 2026FILED +9 DAYS
Source: SEC Form 4 · 0002048497-26-000016 · filed 2026-09-18 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Beta Bionics, Inc. (BBNX)." Disclosed 2026-09-18. https://desqlong.com/cards/0002048497-26-000016-1 (retrieved 2026-09-26).